Tearsheet
Investment Highlights Market Valuation Price Chart Return vs. Risk About ETOR Interactive Breakdown Better Bets vs. ETOR Latest Trefis Analyses Trade Ideas Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

Etoro (ETOR)

Market Price (10/31/2025): $37.415 | Market Cap: $3.0 Bil
Sector: Financials | Industry: Diversified Capital Markets

Etoro (ETOR)

Market Price (10/31/2025): $37.415
Market Cap: $3.0 Bil
Sector: Financials
Industry: Diversified Capital Markets

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 6.1%, FCF Yield is 9.0%		  
1 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -38%		  
0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 6.1%, FCF Yield is 9.0%
1 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -38%

Market Valuation & Key Metrics

ETORS&P 500
REVENUE GROWTHFAIR
Rev LTM ($ Bil)11.1
Rev Chg Q�6.4%
Rev Chg LTM�5.4%
PROFITABILITYVERY POOR
Op Inc LTM ($ Bil)0.2
CFO LTM ($ Bil)0.3
Net Inc LTM ($ Bil)0.2
Op Mgn LTM2.2%18.7%
CFO/Rev LTM2.5%20.4%
Net Inc Mgn1.7%12.8%
VALUATIONLOW
P/S0.33.2
P/CFO11.015.5
P/FCF11.120.6
P/E16.223.6

ETOR Stock

   
   
   
   
   
   
   
Factor Drivers of Stock Movement
null

null
null

null
null

null

Return vs. Risk

Price Returns Compared

 202020212022202320242025Total [1]
Returns
ETOR Return------0%
Peers Return-1%0%0%0%-18%16%-6%
S&P 500 Return16%27%-19%24%23%16%110%

Monthly Win Rates [3]
ETOR Win Rate-----25% 
Peers Win Rate2%0%0%0%10%19% 
S&P 500 Win Rate58%75%42%67%75%67% 

Max Drawdowns [4]
ETOR Max Drawdown------ 
Peers Max Drawdown-1%0%0%0%-19%-36% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 

[1] Cumulative total returns since the beginning of 2020
[2] Peers: ABTC, FIGR, GEMI, GRAN, GSIW.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/30/2025 (YTD)

How Low Can It Go

ETOR has limited trading history. Below is the Financials sector ETF (XLF) in its place.

Unique KeyEventXLFS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-26.9%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven36.7%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven525 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-43.3%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven76.5%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven295 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-26.1%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven35.2%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven338 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-83.7%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven515.2%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven4470 days1480 days

Compare to


In The Past

SPDR Select Sector Fund's stock fell -26.9% during the 2022 Inflation Shock from a high on 1/12/2022. A -26.9% loss requires a 36.7% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Etoro (ETOR)

Better Bets than Etoro (ETOR)

 ETORBetter Performance than ETOR
MetricValueIndustry (Diversified Capital Markets)
Op Mgn LTM2.2%HOOD (39.0%), LPLA (12.9%), TW (39.3%), IREN (4.4%), HUT (59.4%)
CFO/Rev LTM2.5%HOOD (34.0%), LPLA (4.0%), TW (53.9%), XP (145.7%), LAZ (15.8%)
FCF/Rev LTM2.4%HOOD (32.4%), TW (49.2%), XP (140.4%), LAZ (14.4%), PWP (24.8%)
Total Yield6.1%XP (73.6%), LAZ (9.6%), MRX (11.6%), PWP (8.0%), OPY (13.1%)
 ETORBetter Performance than ETOR
MetricValueAll Other Sectors
Op Mgn LTM2.2%NVDA (58.1%), AAPL (31.9%), MSFT (46.3%), GOOGL (32.2%), AMZN (11.4%)
CFO/Rev LTM2.5%NVDA (46.6%), AAPL (26.6%), MSFT (50.0%), GOOGL (39.3%), AMZN (18.1%)
FCF/Rev LTM2.4%NVDA (43.6%), AAPL (23.5%), MSFT (26.6%), GOOGL (19.1%), AVGO (41.6%)
Total Yield6.1%XOM (9.7%), JNJ (8.2%), BABA (36.3%), HD (6.3%), UNH (8.1%)
 Best Bets In Financials Sector
 ETORDBRG OTF MTG NMIH CACC ENVA FNF ACGL APAM FI
What You Pay           
P/E16.339.713.28.47.512.310.213.98.610.510.6
P/EBIT11.664.79.06.45.59.97.88.97.66.15.8
What You Get           
Rev Chg Q�-102.4%1,228.5%-0.7%7.2%8.3%16.3%16.8%22.4%4.4%8.0%
Rev Chg LTM�-84.8%89.0%2.2%10.0%12.5%21.1%7.4%23.5%10.0%6.7%
Rev Chg 3Y Avg�125.8%221.9%1.2%10.1%6.9%23.5%-0.7%29.8%0.2%7.5%
FCF/Rev 3Y Avg�101.2%76.2%62.2%58.8%57.1%54.7%50.8%38.4%29.0%20.7%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 21%, alpha of 9.1%, and sharpe of 0.94

Latest Trefis Analyses

Trade Ideas

Select past ideas related to ETOR. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
HLNE_9302025_Dip_Buyer_FCFYield09302025HLNEHamilton LaneDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		-14.4%-14.4%-14.4%
CNS_9302025_Dip_Buyer_ValueBuy09302025CNSCohen & SteersDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		5.9%5.9%-1.6%
JKHY_9262025_Monopoly_xInd_xCD_Getting_Cheaper09262025JKHYJack Henry & AssociatesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		0.3%0.3%-2.1%
FDS_9192025_Monopoly_xInd_xCD_Getting_Cheaper09192025FDSFactSet Research SystemsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-7.7%-7.7%-7.7%
IBKR_9052025_Quality_Momentum_RoomToRun_10%09052025IBKRInteractive BrokersQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run		15.0%15.0%0.0%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
HLNE_9302025_Dip_Buyer_FCFYield09302025HLNEHamilton LaneDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		-14.4%-14.4%-14.4%
CNS_9302025_Dip_Buyer_ValueBuy09302025CNSCohen & SteersDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		5.9%5.9%-1.6%
JKHY_9262025_Monopoly_xInd_xCD_Getting_Cheaper09262025JKHYJack Henry & AssociatesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		0.3%0.3%-2.1%
FDS_9192025_Monopoly_xInd_xCD_Getting_Cheaper09192025FDSFactSet Research SystemsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-7.7%-7.7%-7.7%
IBKR_9052025_Quality_Momentum_RoomToRun_10%09052025IBKRInteractive BrokersQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run		15.0%15.0%0.0%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1PRAXPraxis Precision Medicines279.1%161.2%
2INBXInhibrx Biosciences131.0%409.8%
3PUMPProPetro99.6%16.2%
4DYNDyne Therapeutics88.4%-0.0%
5VICRVicor85.4%89.2%
6CELCCelcuity74.6%503.2%
7GLUEMonte Rosa Therapeutics73.5%87.5%
8NVTSNavitas Semiconductor72.1%251.8%
9LUMNLumen Technologies70.3%94.7%
10BALYBallys63.4%4.1%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1PMIPicard Medical-62.9%5106.3%
2LRNStride-53.8%-35.8%
3FMCFMC-51.0%-66.6%
4FIFiserv-48.3%-68.3%
5NFENew Fortress Energy-43.6%-91.9%
6VGVenture Global-41.7% 
7OGNOrganon-40.2%-55.0%
8VRNSVaronis Systems-39.5%-21.2%
9ITGRInteger-38.5%-52.2%
10LENZLENZ Therapeutics-37.9%5.5%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Etoro

Financials

ETORABTCFIGRGEMIGRANGSIWMedian
NameEtoro American.Figure T.Gemini S.Grande Garden S. 
Mkt Price37.465.1540.6617.492.700.1611.32
Mkt Cap3.0-----3.0
Rev LTM11,063-----11,063
Op Inc LTM239-----239
FCF LTM270-----270
FCF 3Y Avg-------
CFO LTM274-----274
CFO 3Y Avg-------

Growth & Margins

ETORABTCFIGRGEMIGRANGSIWMedian
NameEtoro American.Figure T.Gemini S.Grande Garden S. 
Rev Chg LTM-------
Rev Chg 3Y Avg-------
Rev Chg Q-------
QoQ Delta Rev Chg LTM-------
Op Mgn LTM2.2%-----2.2%
Op Mgn 3Y Avg-------
QoQ Delta Op Mgn LTM-------
CFO/Rev LTM2.5%-----2.5%
CFO/Rev 3Y Avg-------
FCF/Rev LTM2.4%-----2.4%
FCF/Rev 3Y Avg-------

Valuation

ETORABTCFIGRGEMIGRANGSIWMedian
NameEtoro American.Figure T.Gemini S.Grande Garden S. 
Mkt Cap3.0-----3.0
P/S0.3-----0.3
P/EBIT11.6-----11.6
P/E16.3-----16.3
P/CFO11.0-----11.0
Total Yield6.1%-----6.1%
Dividend Yield0.0%-----0.0%
FCF Yield 3Y Avg-------
D/E0.0-----0.0
Net D/E-0.4------0.4

Returns

ETORABTCFIGRGEMIGRANGSIWMedian
NameEtoro American.Figure T.Gemini S.Grande Garden S. 
1M Rtn-9.2%-23.6%11.8%-27.0%-6.9%6.7%-8.1%
3M Rtn-37.5%--92.3%--40.9%41.6%-39.2%
6M Rtn---92.3%-250.6%-62.8%-62.8%
12M Rtn---92.3%-250.6%-85.4%-85.4%
3Y Rtn---92.3%-250.6%-79.2%
1M Excs Rtn-5.8%-30.1%5.9%-25.0%-11.7%1.0%-8.7%
3M Excs Rtn-44.9%--101.7%--49.6%31.4%-47.3%
6M Excs Rtn---114.1%-228.9%-84.5%-84.5%
12M Excs Rtn---109.5%-233.5%-103.6%-103.6%
3Y Excs Rtn---169.1%-173.9%-2.4%

Financials

$ Mil | FY: 12/312025Q22025Q12024Q22024Q1
Period End6/30/20253/31/20256/30/20243/31/2024
Filing Date8/12/20256/10/20258/12/20256/10/2025
Key Financials Quarterly    
Total Revenue2,0873,7511,8453,380
Net Income30603164
EPS0.380.730.370.78
Key Financials TTM    
Total Revenue TTM11,063---
Net Income TTM185---
Growth Rates Quarterly    
Total Revenue Growth----
Net Income Growth----
Margins Quarterly    
Net Income Margin1.4%1.6%1.7%1.9%
Cash & Debt    
Total Cash1,188736--
Total Debt514700
Net Debt / (Cash)-1,137-689--
Cash Flows Quarterly    
FCF from Operations61907251
Cash Flows TTM    
FCF from Operations TTM274---
Returns to Shareholders Quarterly    
Dividends0000
Share Repurchases-0-0-0-0
Return on Invested Capital (ROIC) Quarterly    
ROIC102.2%133.6%--
Return on Invested Capital (ROIC) TTM    
ROIC TTM146.6%---

Short Interest

Short Interest: As Of Date10152025
Short Interest: Shares Quantity2,442,614
Short Interest: % Change Since 930202537.9%
Average Daily Volume889,569
Days-to-Cover Short Interest2.75
Basic Shares Quantity80,274,455
Short % of Basic Shares3.0%

Returns Analyses

SEC Filings

Expand for More

Report DateFiling DateFiling
630202581220256-K 6/30/2025
331202561020256-K 3/31/2025
123120245152025424B4 12/31/2024
123120232142025DRS/A 12/31/2023
123120202252022F-4/A 12/31/2020

Insider Activity

Expand for More

 

Industry Resources

External Quote Links


Prefer one of these to Trefis? Tell us why.